PROCEPT BioRobotics Corp (PRCT)

Common Shares
Sell: $27.50|Buy: $29.50|Change: 0.30 (-1.07%)

Company profile

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Address





Sector 

Healthcare


Previous key dates

NameKey Date
PROCEPT BioRobotics Corp Annual Report for 20252026-02-27T00:00:00
Investor Day2026-02-25T08:00:00
PROCEPT BioRobotics Corp Fourth Quarter Earnings Conference Call for 20252026-02-24T16:30:00
PROCEPT BioRobotics Corp Fourth Quarter Earnings Results for 20252026-02-24T00:00:00
37th Annual Piper Sandler Healthcare Conference2025-12-02T08:30:00
PROCEPT BioRobotics Corp Third Quarter Earnings Conference Call for 20252025-11-04T16:30:00
PROCEPT BioRobotics Corp Third Quarter Earnings Result for 20252025-11-04T00:00:00
PROCEPT BioRobotics Corp Second Quarter Earnings Conference Call for 20252025-08-06T16:30:00
PROCEPT BioRobotics Corp Second Quarter Earnings Result for 20252025-08-06T00:00:00
2025 Truist Med-Tech Conference2025-06-17T09:00:00
PROCEPT BioRobotics Corp Annual General Meeting for 20252025-06-10T13:00:00
2025 Jefferies Global Healthcare Conference2025-06-05T08:45:00
45 Annual William Blair Growth Stock Conference2025-06-04T11:00:00
2025 Bank of America Health Care Conference2025-05-14T18:00:00
PROCEPT BioRobotics Corp First Quarter Earnings Conference Call for 20252025-04-24T08:00:00
PROCEPT BioRobotics Corp First Quarter Earnings Result for 20252025-04-24T00:00:00
2025 Leerink Partners Healthcare Conference2025-03-11T15:00:00
TD Cowen 45th Annual Healthcare Conference2025-03-04T13:10:00
PROCEPT BioRobotics Corp Annual Report for 20242025-02-27T00:00:00
PROCEPT BioRobotics Corp Fourth Quarter Earnings Conference Call for 20242025-02-25T16:30:00
PROCEPT BioRobotics Corp Fourth Quarter Earnings Result for 20242025-02-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.